• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number UNK LINX MAGNETIC IMPLANT
Device Problem Material Erosion (1214)
Patient Problems Erosion (1750); Dysphagia/ Odynophagia (1815); Obstruction/Occlusion (2422); Abdominal Distention (2601); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Date of event: unknown.The lot was not provided; therefore, the manufacturing records could not be reviewed.
 
Event Description
It was reported via journal article: title: multi-institutional outcomes using magnetic sphincter augmentation versus nissen fundoplication for chronic gastroesophageal reflux disease.Author/s: heather f.Warren, jessica l.Reynolds, john c.Lipham, joerg zehetner, nikolai a.Bildzukewicz, paul a.Taiganides, jody mickley, ralph w.Aye, alexander s.Farivar, brian e.Louie.Citation: surg endosc (2016) 30:3289¿3296; doi 10.1007/s00464-015-4659-y.This is a multi-institutional retrospective cohort study of patients with gerd undergoing magnetic sphincter augmentation (msa) or nissen fundoplication (nf).Between 06 apr 2007 to 12 december 2014, 415 patients underwent either msa of nf for the treatment of chronic gerd.Msa group were 201 patients (male=52%, female=48%; age range 42-64 years, mean age=54 years; bmi=32).Msa implantation was completed using the linx reflux management system (ethicon).Reported complications included gastroesophageal junction (gej) obstruction (n=1) which required to return to the operating room for removal of a crural stitch; failure to control reflux (n=1) at 13 months postoperatively which the patient was converted from msa to nf; device erosion with persistent dysphagia (n=1) 20 months after implantation.Persistent dysphagia was demonstrated a portion of the magnetic sphincter within the esophageal lumen.This was removed by cutting the exposed magnetic beads.Serial endoscopies demonstrated complete healing of the erosion without any further complication.1-year post-operative complaint included mild gas bloat (n=27%); moderate gas bloat (n=14%); severe gas bloat (n=5%); mild dysphagia (n=44%); moderate dysphagia (n=13%); severe dysphagia (n=1%).In conclusion, msa for uncomplicated gerd achieves similar improvements in quality of life and symptomatic relief, with fewer side effects, but lower ppi elimination rates when compared to propensity-matched nf cases.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK LINX MAGNETIC IMPLANT
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
milt garrett
4188 lexington avenue north
shoreview, MN 
MDR Report Key9013346
MDR Text Key161089976
Report Number3008766073-2019-00448
Device Sequence Number1
Product Code LEI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK LINX MAGNETIC IMPLANT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/15/2019
Initial Date FDA Received09/12/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-